KalVista Pharmaceuticals (KALV) FCF Margin (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) FCF Margin (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 25,893.00 |
| Apr 30, 2020 | 50,108.00 |
| Jan 31, 2020 | -62,902.00 |
| Oct 31, 2019 | 13,533.00 |
| Jul 31, 2019 | 3,105.00 |
| Apr 30, 2019 | -8,904.00 |
| Jan 31, 2019 | -11,852.00 |
| Oct 31, 2018 | 2,121.00 |
| Jul 31, 2018 | -3,684.00 |
| Apr 30, 2018 | -134,827.00 |
| Jan 31, 2018 | 185,146.00 |
| Oct 31, 2017 | 409,929.00 |
| Jul 31, 2017 | -242,511.00 |
| Apr 30, 2017 | 221,227.00 |
| Jan 31, 2017 | -240,107.00 |
| Oct 31, 2016 | -154,970.00 |
| Mar 31, 2016 | 681,429.00 |
| Dec 31, 2015 | -250,000.00 |
| Sep 30, 2015 | 1.70 Mn |
| Jun 30, 2015 | -3.27 Mn |